Vaxcyte's new pneumococcal vaccine may only have phase 1/2 results behind it, but analysts are already predicting it could be a major competitor to rival shots from Pfizer and MSD. Just-reported ...

Sanofi has moved ahead with plans to challenge Pfizer and MSD for a piece of the market for pneumococcal vaccines, taking a 21-valent shot licensed from SK Biosciences into phase 3 testing.

KUALA LUMPUR: Pharmaniaga Bhd expects to invest about RM100 million over the next two to three years in facilities to manufacture halal and cost-effective vaccines at its existing life science ...

Read all vaccine information available from your health care professional before receiving the vaccine. If you have any questions, ask your health care professional. This vaccine is injected into ...

“Pharmaniaga offered guidance that there will be no further provisions going forward. It still keeps some unsold vaccines (which have been fully provided for) and has managed to sell some ...

Pneumococcal pneumonia is a potentially serious bacterial lung disease that can disrupt your life for weeks and even land you in the hospital. Medical experts want you to know that there are steps you ...